MedTrace Logo

An Early Stress-Reduction Intervention in Patients With Newly Diagnosed Breast Cancer

NCT03429907 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2025-11-13

No results posted yet for this study

Summary

The goal of this research study is to learn if starting a stress-reduction program before treatment can affect your stress, mood, and physical symptoms during and after treatment for cancer.

This is an investigational study.

Up to 140 participants will be enrolled in this study. All participants will be recruited at MD Anderson.

Conditions

  • Malignant Neoplasm of Breast

Interventions

BEHAVIORAL

Mind-Body Exercises

Participants do daily mind-body exercises for 14 days before starting chemotherapy. The exercises are about 10 minutes per day.

BEHAVIORAL

Questionnaires

Questionnaires completed at baseline, at third and at last cycle of chemotherapy, and 6 months after chemotherapy.

Sponsors & Collaborators

  • Hackett Foundation

    collaborator OTHER

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Keri Schadler, PHD · M.D. Anderson Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-05
Primary Completion
2026-04-30
Completion
2026-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03429907 on ClinicalTrials.gov